Amarin Corp Plc (AMRN)

[Sam81]

Always

I disagree with you 100%
It has nothing to do with getting a label change or being acquired.
The scripts mirror previous years increase/decrease for the same period.

In few weeks, all will be clear especially in terms of insurance coverage and deductibles and it will kick start from there

A more important point to note is that during the ACC in March-2019, in addition to the late-breaking clinical trials, the ACC/American Heart Association Guideline on the Primary Prevention of Cardiovascular Disease will also be released at the meeting

My feeling is that V will be on the guideline and will be practice of care before even getting FDA approval/Label change